Cancer diagnostics firm Personal Genome Diagnostics (PGDx) has raised $65m in an open equity financing round. It aims to raise a total of $111.5m in the round. PGDx offers cancer patients gene analysis to provide better diagnoses and treatments. Thus far, 12 investors have purchased equity. PGDx already gained $21.4m in a series A funding round in Oct. 30, adding to its previous $2.8m in seed funding.
Cancer diagnostics firm Personal Genome Diagnostics (PGDx) has raised $65m in an open equity financing round. It aims to raise a total of $111.5m in the round. PGDx offers cancer patients gene analysis to provide better diagnoses and treatments. Thus far, 12 investors have purchased equity. PGDx already gained $21.4m in a series A funding round in 2015, adding to its previous $2.8m in seed funding.